NADPH oxidase and the degeneration of dopaminergic neurons in Parkinsonian mice

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Hernandes, Marina S ^a   Café Mendes, Cecília C ^a   Britto, Luiz R G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CD11B ANTIGEN; CYBB PROTEIN, MOUSE; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; C57BL MOUSE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NEOSTRIATUM; NERVE DEGENERATION; PARKINSON DISEASE; PATHOLOGY; SUBSTANTIA NIGRA;

ANIMALS; ANTIGENS, CD11B; APOMORPHINE; DOPAMINERGIC NEURONS; ENZYME ACTIVATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NEOSTRIATUM; NERVE DEGENERATION; OXIDOPAMINE; PARKINSON DISEASE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84893865299     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/157857     Document Type: Article

References (36)

1. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models. Neuron 2003 39 6 889 909 2-s2.0-0141741347 10.1016/S0896-6273(03)00568-3 (Pubitemid 37130207)
2. Greenamyre J. T., Hastings T. G., Parkinson's-divergent causes, convergent mechanisms. Science 2004 304 5674 1120 1122 2-s2.0-2442636348 10.1126/science.1098966 (Pubitemid 38661838)
3. Jenner P., Oxidative stress in Parkinson's disease. Annals of Neurology 2003 53 supplement 3 S26 S38 10.1002/ana.10483 (Pubitemid 36368560)
4. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2696 2701 2-s2.0-0029917194 10.1073/pnas.93.7.2696 (Pubitemid 26114311)
5. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P., Halliwell B., A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. Journal of Neurochemistry 1997 69 3 1326 1329 2-s2.0-0030805622 (Pubitemid 27364859)
6. Floor E., Wetzel M. G., Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. Journal of Neurochemistry 1998 70 1 268 275 2-s2.0-0031962268 (Pubitemid 28020852)
7. Giasson B. I., Duda J. E., Murray I. V. J., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q., Lee V. M.-Y., Oxidative damage linked to neurodegeneration by selective α -synuclein nitration in synucleinopathy lesions. Science 2000 290 5493 985 989 2-s2.0-0034602442 10.1126/science.290.5493.985
8. Good P. F., Hsu A., Werner P., Perl D. P., Warren Olanow C., Protein nitration in Parkinson's disease. Journal of Neuropathology and Experimental Neurology 1998 57 4 338 342 2-s2.0-0031939204 (Pubitemid 28182632)
9. Schober A., Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell and Tissue Research 2004 318 1 215 224 2-s2.0-5544229693 10.1007/s00441-004-0938-y (Pubitemid 39366054)
10. Blandini F., Armentero M.-T., Martignoni E., The 6-hydroxydopamine model: news from the past. Parkinsonism and Related Disorders 2008 14 2 S124 S129 2-s2.0-47049116273 10.1016/j.parkreldis.2008.04.015
11. Ungerstedt U., 6-hydroxy-dopamine induced degeneration of central monoamine neurons. European Journal of Pharmacology 1968 5 1 107 110 2-s2.0-0014376793
12. Rodriguez-Pallares J., Parga J. A., Muñoz A., Rey P., Guerra M. J., Labandeira-Garcia J. L., Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. Journal of Neurochemistry 2007 103 1 145 156 2-s2.0-34548620779 10.1111/j.1471-4159.2007.04699.x (Pubitemid 47404195)
13. Brown D. I., Griendling K. K., Nox proteins in signal transduction. Free Radical Biology and Medicine 2009 47 9 1239 1253 2-s2.0-70349804297 10.1016/j.freeradbiomed.2009.07.023
14. Montezano A. C., Touyz R. M., Oxidative stress, noxs, and hypertension: experimental evidence and clinical controversies. Annals of Medicine 2012 44 supplement 1 S2 S16 10.3109/07853890.2011.653393
15. Kahles T., Brandes R. P., NADPH oxidases as therapeutic targets in ischemic stroke. Cellular and Molecular Life Sciences 2012 69 14 2345 2363 10.1007/s00018-012-1011-8
16. Molina-Luna K., Pekanovic A., Röhrich S., Hertler B., Schubring-Giese M., Rioult-Pedotti M.-S., Luft A. R., Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. Plos One 2009 4 9 2-s2.0-70349400360 10.1371/journal.pone.0007082 e7082
17. Paxinos G., Franklin K., The Mouse Brain in Stereotaxic Coordinates 2007 New York, NY, USA Academic Press
18. Zarrindast M. R., Sedaghati F., Borzouyeh F., Nicotine-induced grooming: a possible dopaminergic and/or cholinergic mechanism. Journal of Psychopharmacology 1998 12 4 375 379 2-s2.0-0031775377 (Pubitemid 28561442)
19. Zhang Y., Chan M. M. K., Andrews M. C., Mori T. A., Croft K. D., McKenzie K. U. S., Schyvens C. G., Whitworth J. A., Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. American Journal of Hypertension 2005 18 7 910 916 2-s2.0-22844432344 10.1016/j.amjhyper.2005.02.017 (Pubitemid 41040260)
20. Morrison H. W., Filosa J. A., A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. Journal of Neuroinflammation 2013 10 4 10 14 10.1186/1742-2094-10-4
21. Montaña M., del Caño G. G., de Jesús M. L., González-Burguera I., Echeazarraa L., Barrondoa S., Sallés J., Cellular neurochemical characterization and subcellular localization of phospholipase C β 1 in rat brain. Neuroscience 2012 222 239 268 10.1016/j.neuroscience.2012.06.039
22. Babior B. M., The activity of leukocyte NADPH oxidase: regulation by p47PHOX cysteine and serine residues. Antioxidants and Redox Signaling 2002 4 1 35 38 2-s2.0-0036196174 (Pubitemid 34260684)
23. Sayre L. M., Smith M. A., Perry G., Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Current Medicinal Chemistry 2001 8 7 721 738 2-s2.0-0035003439 (Pubitemid 32427903)
24. Hernandes M. S., Britto L. R., NADPH oxidase and neurodegeneration. Current Neuropharmacology 2012 10 4 321 327 10.2174/157015912804143540.
25. Wu D.-C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., Przedborski S., NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6145 6150 2-s2.0-0037947448 10.1073/pnas.0937239100 (Pubitemid 36576945)
26. Wu D.-C., Ré D. B., Nagai M., Ischiropoulos H., Przedborski S., The inflammatory NADPH oxidase enzyme modulates motor neuron degradation in amyotrophic lateral sclerosis mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 32 12132 12137 2-s2.0-33747047814 10.1073/pnas.0603670103 (Pubitemid 44215823)
27. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H. H. H. W., Busse R., Schröder K., Brandes R. P., Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008 51 2 211 217 2-s2.0-38549138327 10.1161/HYPERTENSIONAHA.107.100214 (Pubitemid 351159930)
28. Wang Q., Smith R. E., Luchtefeld R., Sun A. Y., Simonyi A., Luo R., Sun G. Y., Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocynin. Phytomedicine 2008 15 6-7 496 503 2-s2.0-44849113246 10.1016/j.phymed.2007.09.019 (Pubitemid 351790760)
29. Trumbull K. A., McAllister D., Gandelman M. M., Fung W. Y., Lew T., Brennan L., Lopez N., Morré J., Kalyanaraman B., Beckman J. S., Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice. Neurobiology of Disease 2012 45 1 137 144 2-s2.0-81955168003 10.1016/j.nbd.2011.07.015
30. Gao H.-M., Liu B., Hong J.-S., Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. Journal of Neuroscience 2003 23 15 6181 6187 2-s2.0-0038044029 (Pubitemid 36875618)
31. Gao H.-M., Liu B., Zhang W., Hong J.-S., Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. The FASEB Journal 2003 17 13 1954 1956 2-s2.0-0347334401 10.1096/fj.03-0109fje
32. Iancu R., Mohapel P., Brundin P., Paul G., Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behavioural Brain Research 2005 162 1 1 10 2-s2.0-19444370500 10.1016/j.bbr.2005.02.023 (Pubitemid 40726275)
33. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., Mcauliffe W. G., Dawson V. L., Dawson T. M., Przedborski S., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine 1999 5 12 1403 1409 2-s2.0-0032710609 10.1038/70978
34. Rodrigues R. W. P., Gomide V. C., Chadi G., Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. International Journal of Neuroscience 2001 109 1-2 91 126 2-s2.0-0034846276 (Pubitemid 32832158)
35. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.-K., Ischiropoulos H., Przedborski S., Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience 2002 22 5 1763 1771 2-s2.0-0036522967 (Pubitemid 35386294)
36. Gao H.-M., Jiang J., Wilson B., Zhang W., Hong J.-S., Liu B., Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. Journal of Neurochemistry 2002 81 6 1285 1297 2-s2.0-0036316772 10.1046/j.1471-4159.2002. 00928.x (Pubitemid 34809262)